Drug Shortage Report for MAR-GABAPENTIN
| Report ID | 106482 |
| Drug Identification Number | 02391503 |
| Brand name | MAR-GABAPENTIN |
| Common or Proper name | GABAPENTIN |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | DORMANT |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 400MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 500 TABLET |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2020-02-21 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-02-22 |
| Company comments | Not bringing new supply |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-02-22 | English | Compare |
| v2 | 2020-02-18 | French | Compare |
| v1 | 2020-02-18 | English | Compare |
Showing 1 to 3 of 3